Kite, a Gilead Company, is a biopharmaceutical company at the forefront of developing and commercializing innovative cancer immunotherapy products. Their focus is on engineered T cell therapies, such as CAR T-cell therapy, designed to harness the power of a patient's own immune system to target and kill cancer cells. Kite is dedicated to advancing science and delivering potentially curative therapies to patients with hematologic cancers and solid tumors.
Serves as the central hub for Kite's global operations, including research and development leadership, corporate strategy, and administrative functions for its pioneering work in cell therapy.
State-of-the-art facilities designed to support cutting-edge research and development in cell therapy, including advanced laboratories and collaborative workspaces. Proximity to other biotech companies and research institutions.
A fast-paced, innovative, and patient-focused environment driven by a mission to cure cancer. Emphasis on collaboration, scientific excellence, and a sense of urgency in bringing transformative therapies to patients.
The Santa Monica headquarters is central to Kite's identity as a leader in CAR T-cell therapy, housing key decision-makers and research teams driving the company's scientific advancements.
Kite, as a Gilead company, supports global functions including research and development, clinical trials, manufacturing, and commercialization of its cell therapies. Key operational hubs are in North America (USA) and Europe (Netherlands), with a growing reach to make its therapies available to patients worldwide through Gilead's established international infrastructure.
2400 Broadway
Santa Monica
California
USA
Address: 9021 Bennett Creek Blvd, Frederick, MD 21704, USA
Serves as a key node in Kite's manufacturing network, enabling the production and supply of cell therapies to patients in North America. Supports the company's commitment to reliable and timely delivery of these life-saving treatments.
Address: Taurusavenue 107, 2132 LS Hoofddorp, Netherlands
Ensures the supply of Kite's innovative cell therapies to patients across Europe and supports the company's growing presence and market access in the region. It's a strategic hub for European clinical development and commercial activities.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Kite Pharma' leadership includes:
Kite Pharma has been backed by several prominent investors over the years, including:
Kite has seen strategic leadership appointments and transitions over the last 12 months to further strengthen its capabilities in cell therapy development and commercialization. Key movements focus on enhancing research, clinical development, and overall leadership.
Discover the tools Kite Pharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
As Kite is a Gilead company, email formats generally follow Gilead Sciences' corporate conventions. The most common format observed is [firstname].[lastname]@gilead.com. While variations might exist, this pattern is standard for corporate communications.
[first].[last]@gilead.com
Format
jane.doe@gilead.com
Example
85%
Success rate
Fierce Pharma • May 8, 2024
Kite is experiencing high demand for its CAR T-cell therapy Yescarta, leading to manufacturing capacity challenges as it prepares for a potential new BCMA-targeted CAR-T therapy launch and aims to expand access....more
Gilead Sciences Press Room • April 29, 2024
Results from the Phase 3 ZUMA-7 study showed that Kite's Yescarta (axicabtagene ciloleucel) demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) compared to standard of care for adult patients with relapsed or refractory large B-cell lymphoma (LBCL) after first-line chemoimmunotherapy....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Kite Pharma, are just a search away.